NCT00610428View on ClinicalTrials.gov

Staccato Prochlorperazine in Migraine (in Clinic)

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Migraine Headache, With or Without Aura
Interventions
DRUG

Staccato Placebo

Inhaled Staccato Placebo

DRUG

Staccato Prochlorperazine 5 mg

Inhaled Prochlorperazine 5 mg

DRUG

Staccato Prochlorperazine 10 mg

Inhaled Prochlorperazine10 mg

Trial Locations (1)

10550

Arthur H. Elkind, MD, Mount Vernon

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY